Immutep (ASX:IMM) - Webinar Presentation Company Presentations by Finance News Network February 16, 2024 03:45 PM Email Alerts for: ASX:IMM Marc Voigt, Executive Director & CEO, Immutep (ASX:IMM) is a clinical-stage biotechnology company at the forefront of developing novel LAG-3 immunotherapy for cancer and autoimmune diseases.
